For the first time in 15 years, Downtown Los Angeles will have a new person at the helm of Council District 14. On March 3, Downtown voters will have the opportunity to cast their votes for one of ...
Researchers have uncovered a drug-like compound that blocks a crucial inflammatory pathway, potentially paving the way for a new treatment for a host of diseases -- including COVID-19. The team ...
Clinical and analytical performance of non-small cell lung cancer biomarkers. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text component ...
PERTH, Australia – Implicit Bioscience Ltd.’s lead candidate, IC-14, is the first anti-CD14 monoclonal antibody (MAb) to progress to the clinic as it enters a phase II trial in the U.S. in COVID-19 ...
A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalized with respiratory disease and low blood oxygen due to infection with ...
Economic impact of progressive disease (PD) following frontline therapy in classical Hodgkin lymphoma (HL). This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results